Converge BioConverge Bio
Converge Bio

Converge Bio

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Website
2023Active51
Advertise here

About

Converge Bio is a Generative AI Lab for the Life Sciences that accelerates drug development through AI-powered innovations in discovery, molecule design, and manufacturing. Their platform offers solutions for antibody design and screening, gene expression optimization, and target and biomarker discovery. Converge Bio serves pharmaceutical and biotech companies seeking to create tomorrow's therapies today.

Technology stack

detected 2026-06-15
Est. monthly stack spend~$440/mo
EmailGoogle Workspace
Stack
Framer
Analytics
Google Tag ManagerMicrosoft Clarity
Cookie consent
Cookiebot
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Converge Bio do?

Converge Bio is a Generative AI Lab for the Life Sciences that accelerates drug development through AI-powered innovations in discovery, molecule design, and manufacturing. Their platform offers solutions for antibody design and screening, gene expression optimization, and target and biomarker discovery. Converge Bio serves pharmaceutical and biotech companies seeking to create tomorrow's therapies today.

How much funding has Converge Bio raised?

Converge Bio has raised a total of $6M in funding. The most recent round on record is Seed.

Where is Converge Bio headquartered?

Converge Bio is headquartered in San Francisco, United States.

When was Converge Bio founded?

Converge Bio was founded in 2023.

What industry does Converge Bio operate in?

Converge Bio operates in Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical, Foundation Models, Open Source.

How many employees does Converge Bio have?

Converge Bio has approximately 51 people on record.